Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
1 (100.0%)Infant Formula Feeding and Necrotizing Enterocolitis in Newborns
- Conditions
- Cows Milk AllergyNecrotizing EnterocolitisNecrotizing Enterocolitis of NewbornSepsis Newborn
- First Posted Date
- 2021-11-16
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- Neuroganics LLC
- Target Recruit Count
- 1000
- Registration Number
- NCT05121753
- Locations
- πΊπΈ
10190 Bannock St #102, Northglenn, Colorado, United States
National Vaccine Adverse Event Reporting Survey and Etiology
- Conditions
- Vaccine ReactionBlood ClotThrombocytopeniaGWASGenetic SequencingCOVID-19Vaccine Adverse ReactionGuillain-BarrΓ©Corona Virus InfectionNeuritis
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- Neuroganics LLC
- Target Recruit Count
- 100000
- Registration Number
- NCT05095844
- Locations
- πΊπΈ
Neuroganics LLC, Northglenn, Colorado, United States
COVID-19 Diagnostic Self-testing Using Virtual Point-of-care
Not Applicable
- Conditions
- Sars-CoV2Communicable DiseaseVirusCOVID-19Infectious DiseaseCoronavirus
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2022-03-23
- Lead Sponsor
- Neuroganics LLC
- Target Recruit Count
- 200
- Registration Number
- NCT04348864
- Locations
- πΊπΈ
Neuroganics, Northglenn, Colorado, United States
News
No news found